Category: News
-
U-M BME Researchers Develop Nanoparticle Therapy to Boost the Immune System’s Attack on Metastatic Cancer
This innovation could mark a major turning point in how metastatic cancers are treated in the future.
-
BME Celebrates 20 Years of Coulter Translational Research Partnership Program Success Stories
Pioneering Neuroma Prevention to Advanced Prosthetic Control
-
Innovative Biomaterial Scaffolds Enable Precise Recruitment and Study of Rare Antigen-Specific T Cells
A collaborative team led by U-M BME develops a controlled-release platform to advance immune cell research and unlock new possibilities in autoimmune disease monitoring.
-
New Capsule Technology Shows Promise for Restoring Lost Ovarian Function due to Cancer Treatments
U-M Biomedical Engineering researchers make strides toward improving quality of life for pediatric cancer survivors.
-
A New Window into Brain Health: U-M’s Researchers Develop Non-Invasive MRI Technique to Track Water Movement at the Microscopic Level
For scientists and clinicians alike, being able to “watch” water move inside the brain may help unlock mysteries of aging, Alzheimer’s, and more.
-
Collins Chimezie Receives Rackham International Fellowship
Award enables expanded focus on targeting bacterial toxins through probiotics, with the goal of reducing colorectal cancer and inflammatory bowel disease risk.
-
Michigan Synthetic Biology Team Earns Gold at International iGEM Competition in Paris
The team’s novel bacterial cancer therapy caught the attention of judges and fellow innovators alike—using innovative synthetic biology to tackle one of medicine’s most persistent challenges: targeted ovarian cancer treatment.
-
BME Launches Department Chair Search
The deadline for ensuring full consideration of an application is January 31, 2026, but the position will remain open, and applications will continue to be considered until the position is filled.
-
Jiahe Li Lab Examines Breakthrough in Engineering Probiotic Defenses Against Early-Onset Colon Cancer
Dr. Li’s team has developed an engineered probiotic designed to neutralize genotoxic threats in the gut, shifting the focus from treatment to prevention in colon cancer research.
-
Zhen Xu Named Finalist for 2026 Sony Women in Technology Award with Nature
This award recognizes three early to mid-career women researchers in technology whose work is driving positive impact on society and the planet. Winners will be announced in February.